Related Articles
Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients
Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer
PLEKHS1: A new molecular marker predicting risk of progression of non‑muscle‑invasive bladder cancer
Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: A southwest oncology group study
Androgen deprivation therapy regulation of β1C integrin expression in prostate cancer